piracetam has been researched along with cyclosporine in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 9 (69.23) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Baik, JH; Cho, YS; Choi, K; Jang, HS; Jung, SH; Kim, YS; Ko, MK; Lee, J; Lee, JK; Min, SJ; Pae, AN; Park, BG | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Cho, S; Cho, SJ; Jung, SY; Kim, T; Lee, J; Min, SJ; Mook-Jung, I; Pae, AN; Park, BG; Park, JH; Park, KD; Song, H; Tae, J; Yang, H; Yang, HY | 1 |
| Elkamhawy, A; Hassan, AHE; Lee, J; Moon, B; Pae, AN; Park, BG; Park, HM; Park, JE; Ra, H; Roh, EJ | 1 |
| Elkamhawy, A; Hassan, AHE; Lee, J; Pae, AN; Paik, S; Park, BG; Park, JE; Roh, EJ | 2 |
| Elkamhawy, A; Hassan, AHE; Lee, J; Pae, AN; Park, BG; Park, JE; Roh, EJ | 1 |
| Alivanis, P; Grekas, D; Kalekou, H; Karamouzis, M; Papayianni, K; Tourkantonis, A | 1 |
| Baltes, S; Fedrowitz, M; Gastens, AM; Kaever, V; Löscher, W; Potschka, H | 1 |
| Franzoni, E; Garone, C; Malaspina, E; Marchiani, V; Sarajlija, J | 1 |
| Costa, RA; de Souza-Pinto, NC; Fernandes, MP; Vercesi, AE | 1 |
13 other study(ies) available for piracetam and cyclosporine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Synthesis and evaluation of oxime derivatives as modulators for amyloid beta-induced mitochondrial dysfunction.
Topics: Amyloid beta-Peptides; Animals; Cells, Cultured; Humans; Male; Mice; Mice, Inbred ICR; Mitochondria; Mitochondrial Membranes; Molecular Structure; Oximes; Rats; Rats, Sprague-Dawley | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Discovery of benzimidazole derivatives as modulators of mitochondrial function: A potential treatment for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzimidazoles; Cognition; Humans; Ligands; Male; Membrane Potential, Mitochondrial; Memory; Mice, Transgenic; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Models, Molecular; Rats, Sprague-Dawley; Receptors, GABA | 2017 |
Discovery of 1-(3-(benzyloxy)pyridin-2-yl)-3-(2-(piperazin-1-yl)ethyl)urea: A new modulator for amyloid beta-induced mitochondrial dysfunction.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Survival; Cells, Cultured; Cyclosporine; Drug Discovery; Hippocampus; Immunosuppressive Agents; Membrane Potential, Mitochondrial; Mice; Mitochondria; Mitochondrial Membrane Transport Proteins; Molecular Docking Simulation; Neurons; Piperazines; Protein Conformation; Urea | 2017 |
Synthesis and evaluation of new pyridyl/pyrazinyl thiourea derivatives: Neuroprotection against amyloid-β-induced toxicity.
Topics: Amyloid beta-Peptides; Animals; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Mice; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Models, Molecular; Molecular Structure; Neuroprotective Agents; Small Molecule Libraries; Structure-Activity Relationship; Thiourea | 2017 |
Synthesis and evaluation of 2-(3-arylureido)pyridines and 2-(3-arylureido)pyrazines as potential modulators of Aβ-induced mitochondrial dysfunction in Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cell Death; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Humans; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Molecular Docking Simulation; Molecular Structure; Pyrazines; Pyridines; Structure-Activity Relationship | 2018 |
Pyrazinyl ureas revisited: 1-(3-(Benzyloxy)pyrazin-2-yl)-3-(3,4-dichlorophenyl)urea, a new blocker of Aβ-induced mPTP opening for Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Ether-A-Go-Go Potassium Channels; Hippocampus; Humans; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Models, Molecular; Molecular Structure; Neural Stem Cells; Neuroprotective Agents; Pyrazines; Structure-Activity Relationship; Urea | 2018 |
Acute cyclosporin A renal dysfunction in dogs reversed by calcium antagonists and antiplatelet agents.
Topics: Animals; Calcium Channel Blockers; Cyclosporine; Dogs; Drug Interactions; Kidney; Kidney Tubular Necrosis, Acute; Nifedipine; Piracetam; Platelet Aggregation Inhibitors; Thromboxane A2; Thromboxane B2; Time Factors; Vasoconstriction | 1992 |
Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human and mouse P-glycoprotein.
Topics: Analysis of Variance; Animals; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Biological Transport; Carbamazepine; Cell Line; Cyclosporine; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Gene Expression; Humans; Levetiracetam; Mice; Phenytoin; Piracetam; Transfection | 2007 |
No kinetic interaction between levetiracetam and cyclosporine: a case report.
Topics: Adolescent; Anticonvulsants; Cardiomyopathy, Dilated; Cyclosporine; Enzyme Inhibitors; Epilepsy; Female; Heart Transplantation; Humans; Levetiracetam; Piracetam | 2007 |
Protective effects of l-carnitine and piracetam against mitochondrial permeability transition and PC3 cell necrosis induced by simvastatin.
Topics: Carnitine; Cell Line, Tumor; Cyclosporine; Drug Synergism; Humans; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Necrosis; Piracetam; Simvastatin; Superoxides | 2013 |